Moorfields Eye Hospital Dubai restores sight to 83 year-old patient
[caption id="attachment_7197" align="alignnone" width="500"]
Dr Irfan Khan[/caption]
A team from Moorfields Eye Hospital Dubai has successfully treated an elderly patient from Saudi Arabia, restoring the patient’s sight in one eye after he spent 18 months with no sight in either eye. 83 year-old Mr Hassan Al Shaikh Ahmad is now mobile and independent again, after a series of procedures performed in Dubai by Dr. Muhammad Irfan Khan, consultant ophthalmologist with a special interest in strabismus and cataract.
http://www.moorfields.nhs.uk/news/moorfields-eye-hospital-dubai-restores-sight-83-year-old-patient
Dr Irfan Khan[/caption]
A team from Moorfields Eye Hospital Dubai has successfully treated an elderly patient from Saudi Arabia, restoring the patient’s sight in one eye after he spent 18 months with no sight in either eye. 83 year-old Mr Hassan Al Shaikh Ahmad is now mobile and independent again, after a series of procedures performed in Dubai by Dr. Muhammad Irfan Khan, consultant ophthalmologist with a special interest in strabismus and cataract.
http://www.moorfields.nhs.uk/news/moorfields-eye-hospital-dubai-restores-sight-83-year-old-patient
Latest Articles
Making Female Leadership More than a Moment
A remarkable global confluence of women in key positions.
ESCRS Talks Technology at AAO
Europe adopts technological advances, US still waiting for lenses and lasers.
Sorting Out Simultaneous Vision IOLs
The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.
Big Advantages to Small-Aperture IOLs
Small-aperture IOLs offer superior image quality with increased range of focus.
Prioritising Self-Care
Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.
Valuing Clinical Trial Design
How inclusivity and diversity can enhance scientific accuracy in research.
Knowing Iris Repair: Using Iridodiathermy in Iris Surgery
Prepare for decentred pupils and uneven irides in multiple situations.
Neuroprotectant Treatment for MacTel Type 2
Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.